Abstract

Hepatitis C virus (HCV) infection promotes autophagic degradation of viral replicative intermediates for sustaining replication and spread. The excessive activation of autophagy can induce cell death and terminate infection without proper regulation. A prior publication from this laboratory showed that an adaptive cellular response to HCV microbial stress inhibits autophagy through beclin 1 degradation. The mechanisms of how secretory and degradative autophagy are regulated during persistent HCV infection is unknown. This study was performed to understand the mechanisms of viral persistence in the absence of degradative autophagy, which is essential for virus survival. Using HCV infection of a CD63-green fluorescence protein (CD63-GFP), labeled stable transfected Huh-7.5 cell, we found that autophagy induction at the early stage of HCV infection increased the degradation of CD63-GFP that favored virus replication. However, the late-stage of persistent HCV infection showed impaired autophagic degradation, leading to the accumulation of CD63-GFP. We found that impaired autophagic degradation promoted the release of extracellular vesicles and exosomes. The impact of blocking the release of extracellular vesicles (EVs) on virus survival was investigated in persistently infected cells and sub-genomic replicon cells. Our study illustrates that blocking EV and exosome release severely suppresses virus replication without effecting host cell viability. Furthermore, we found that blocking EV release triggers interferon lambda 1 secretion. These findings suggest that the release of EVs is an innate immune escape mechanism that promotes persistent HCV infection. We propose that inhibition of extracellular vesicle release can be explored as a potential antiviral strategy for the treatment of HCV and other emerging RNA viruses.

Highlights

  • The Hepatitis C virus (HCV) is a blood-borne pathogen causing chronic inflammation of the liver without any significant symptoms over several decades that, if untreated, leads to cirrhosis and, potentially, to the development of hepatocellular carcinoma (HCC) [1,2,3]

  • Data presented in this study are consistent with previous reports of other investigators, suggesting that autophagy induction is beneficial for HCV replication [30,39]

  • We found that autophagy inducer Torin1 promoted HCV replication and extracellular vesicle release, as well as lysosomal DQ-BSA degradation

Read more

Summary

Introduction

The Hepatitis C virus (HCV) is a blood-borne pathogen causing chronic inflammation of the liver without any significant symptoms over several decades that, if untreated, leads to cirrhosis and, potentially, to the development of hepatocellular carcinoma (HCC) [1,2,3]. The mechanisms of virus and host interaction that dictate the pathogenesis of chronic liver disease, cirrhosis, and HCC are not well understood This knowledge is essential for developing a biomarker for the early detection of cirrhosis and HCC after an HCV cure. Autophagy starts declining during the chronic stage of liver disease, leading to a reduced clearance of misfolded proteins and cellular constituents that results in the development of liver fibrosis and HCC [12]. How the adaptive cellular response to HCV-microbial stress modulates the autophagy pathway to improve cell survival and HCC development during chronic HCV infection is unknown. This knowledge is essential to prevent virus-associated pathological conditions, such as liver cirrhosis and HCC

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call